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Background:  It was well-known that smoking affects the cardiovascular system, and remifentanil can suppress the 
sympathetic stimulations induced by tracheal intubation.  The purpose of this study was to investigate whether there 
was any difference in the hemodynamic changes induced by tracheal intubation with using remifentanil between 
smokers and nonsmokers. 
Methods:  Eighty patients were enrolled:  male smokers (MS), male nonsmokers (MN), female smokers (FS) and 
female nonsmokers (FN).  Anesthesia was induced with diluted remifentanil (20 μg/ml) at a rate of 10 μg/kg/hr 
using an infusion pump, and 2 min later, midazolam 0.05 mg/kg and propofol 0.8 mg/kg were injected for achieving 
unconsciousness.  Rocuronium 1 mg/kg was used for muscle relaxation, and tracheal intubation was performed 
2 min after rocuronium injection.  After tracheal intubation, the remifentanil was decreased to 2 μg/kg/hr.  The 
mean arterial pressure (MAP) and heart rate (HR) were checked before induction, on unconsciousness, just before 
intubation, just after intubation and 1, 2 and 3 minutes after intubation, and these values were compared between 
the groups. 
Results:  In men, the MAP and HR just after intubation and at 1, 2 and 3 minutes after intubation in Group MS 
were significantly higher than those of Group MN (P < 0.05).  For the women, the HR in both groups (the FS and 
FN groups) were increased just after intubation and 1, 2 and 3 minutes after intubation compared with that at the 
baseline, respectively, but there was no difference between the two groups. 
Conclusions:  There was a difference of the hemodynamic changes induced by tracheal intubation with using 
remifentanil between the male smokers and nonsmokers, but not in women.  (Korean J Anesthesiol 2010; 58: 508-513)
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Introduction
    The recent developments in intravenous anesthetics have 
allowed intravenous anesthetics to move from being com-
plimentary to becoming the main anesthetics during surgery. 
Propofol and remifentanil’s context-sensitive half times are 
short. So, in the setting of total intravenous anesthesia, even 
when the anesthesia is performed over a long period of time, 
the recovery time is quite short compared to that of inhalational 
anesthetics [1]. Remifentanil is an opioid with one of the 
shortest context-sensitive half times. During endotracheal 
intubation, it inhibits the activation of the sympathetic nervous 
system and prevents increases of the blood pressure and heart 
rate. Much research has been done on the optimal dose for 
these effects [2]. There are many reports of clinical situations 
where certain dosage amounts of remifentanil suppressed the 
hemodynamic and cardiovascular responses from endotracheal 
intubation in hypertensive patients [3], elderly patients [4] and 
diabetic patients [5]. 
    Smokers are known to have an extremely increased cardio-
vascular response compared to that of nonsmokers [6,7]. Yet, 
there have hardly been any reports on the appropriate dosages 
of remifentanil for smokers and nonsmokers to repress the 
cardiovascular response to endotracheal intubation. For 
smokers, endotracheal intubation increases the myocardial 
oxygen demand, but it constricts the coronary artery, which 
elevates vascular resistance and reduces the blood flow rate [8]. 
So preventing the hemodynamic changes due to endotracheal 
intubation is very important. We attempted to determine if 
there is a difference between smokers and nonsmokers for their 
cardiovascular response to remifentanil that is administered for 
endotracheal intubation.
Materials and Methods
    Eighty ASA I & II patients of both genders and whose ages 
were between 30 and 60 and the BMI ranged from 20 to 30 
were enrolled in the study. In each gender group, there were 20 
smokers and 20 nonsmokers. The gender groups were divided 
into male smokers (Group MS), male nonsmokers (Group MN), 
female smokers (Group FS) and female nonsmokers (Group 
FN), resulting in 4 subgroups. After the approval of the local 
ethics committee, the authors conducted a preanesthetic visit 
with the patients. The patients gave us their written informed 
consent after they were told of the purpose and methodology of 
the research.
    During the preanesthetic visit before surgery, the authors 
made inquiries about whether or not the patients were 
smokers. If they had a history of smoking for 2 or more years 
and they still smoked, then they were placed in the smoking 
group. The duration of smoking (in months) and the quantity 
of smoking (number of cigarettes per day) were recorded and 
we recommended that patients should stop smoking after the 
preanesthetic visit. If the patient had never smoked, then they 
were put in the nonsmoking group. Patients were excluded 
if they had hypertension, diabetes mellitus, neurological 
disorders or a past history of taking cardiovascular drugs such 
as beta blockers. Patients were excluded if they were expected 
to have difficult intubation or if they did not have successful 
endotracheal intubation on the first try.
    As premedication, 30 minutes before the surgery, intramu-
scular injection was done with ranitidine (Urantac
Ⓡ, Whanin, 
Korea) 25 mg and midazolam (Dormicum
Ⓡ, Roche, Switzerland) 
2.5 mg. The patients were monitored during anesthetic 
induction with electrocardiography, noninvasive blood pressure 
measurement and a pulse oxymeter. Lactated Ringer' solution 
was administered as intravenous fluid with an 18 G angio 
needle in a forearm vein. For prehydration, 1/2 of the calculated 
maintenance volume (2 ml/kg/hr), with considering the NPO 
time, was infused before induction. Induction of anesthesia was 
done according to the methodology of Shim et al. [2] as follows. 
Remifentanil (Ultiva
TM, GSK, Italy) 1 mg was diluted with 50 ml 
of normal saline (20 μg/ml), and then using an infusion pump 
(Pilot C, Fresenius Vial, France), continuous infusion was started 
at a rating of 10 μg/kg/hr concomitant with administering 6 L/
min oxygen with a face mask for 2 minutes. Two minutes after 
remifentanil infusion, midazolam 0.05 mg/kg and propofol 
(Provive
TM, Claris, India) 0.8 mg/kg were administered by 
intravenous injection to induce unconsciousness. If the patient 
did not lose consciousness within 1 minute, then propofol 20 
mg was additionally administered. The loss of consciousness 
was checked by the eyelash reflex. Rocuronium (Esmeron
Ⓡ, 
Organon, Netherlands) 1 mg/kg was intravenously injected 
over a period of 10 seconds. After controlled ventilation for 2 
minutes, endotracheal intubation was performed. Afterwards, 
the remifentanil infusion was reduced to 2 μg/kg/hr. With the 
control mode ventilation, anesthesia was maintained with 
sevoflurane 1.5% in O2 : Air = 1.5 L : 2.5 L/min, with a tidal 
volume of 10 ml/kg and a respiratory rate of 10 bpm. 
    The measurements of the mean arterial pressure (MAP) 
and heart rate (HR) were done before anesthetic induction 
(baseline), at the time of just falling unconsciousness, just 
before endotracheal intubation, just after intubation and 1, 2 
and 3 minutes after intubation. During anesthetic induction, 
when the systolic blood pressure fell below 80 mmHg, the 
administration of remifentanil was stopped. 
    All the measurements are shown as the mean ± standard 
deviation. SPSS 17.0 (SPSS, Inc., Chicago, IL) was used for 
statistical analysis. The height, weight and the dosage of 
remifentanil and the total amount of infused propofol were 510 www.ekja.org
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compared using the Student t-test. The comparisons of heart 
rates and the MAP between the groups were done using the 
independent t-test. The changes over time of the heart rates 
and MAPs within the groups were compared using repeated 
measures of ANOVA test. P values < 0.05 were considered to be 
significant. 
Results 
    There was no significant difference between the male smokers 
and nonsmokers and between female smokers and nonsmokers 
for age, weight, height, the administered remifentanil dose 
and the propofol dose until endotracheal intubation (Table 1). 
None of the patients had their remifentanil infusion stopped 
because none of the patients had a decreased systolic blood 
pressure below 80 mmHg during anesthetic induction. There 
was no difference between the smokers and nonsmokers for the 
baseline MAPs and heart rates. The average duration of smoking 
for men was 17.1 years and the average amount smoked was 24 
cigarettes per day. For women, the average duration of smoking 
was 12.7 years. They smoked on average 18 cigarettes per day.
    In Group MN, there was no difference between the baseline 
MAP and the MAP just after endotracheal intubation. In Group 
MS, the MAP just after endotracheal intubation was significantly 
increased as compared with the baseline MAP (110.1 ± 17.3 
mmHg vs 87.9 ± 4.6 mmHg, respectively) and the MAPs were 
significantly increased at just after endotracheal intubation 
(110.1 ± 17.3 mmHg vs 88.8 ± 14.6 mmHg, respectively) and at 1, 
2 and 3 minutes after intubation, as compared with Group MN, 
respectively (Fig. 1A, P < 0.05). In group MN, the heart rate was 
significantly increased just after endotracheal intubation (72.5 
± 11.4 bpm vs 64.1 ± 3.5 bpm, respectively) and 1 and 2 minutes 
after intubation as compared with the baseline heart rate (Fig. 
1B, P < 0.05). In Group MS, the heart rate was significantly 
increased just after endotracheal intubation (88.5 ± 16.5 bpm 
vs 68.3 ± 8.74 bpm) and at 1, 2 and 3 minutes after intubation 
as compared with baseline, respectively, and these values were 
higher than those of Group MN (Fig. 1B, P < 0.05). 
    For women, there was no difference between Group FN 
and Group FS for the MAP measured just after endotracheal 
Table 1. Demographic Data 
Group MS Group MN Group FS Group FN
Age (yr)
Weight (kg)
Height (cm)
Remifentanil dose (μg)
Propofol dose (mg)
Baseline MAP (mmHg)
Baseline HR (bpm)
 56.3 ± 9.4
 76.0 ± 8.6
172.7 ± 2.6
   81.6 ± 11.0
60.8 ± 6.9
 87.9 ± 4.7
68.3 ± 8.7
 54.2 ± 8.1
 72.6 ± 7.1
171.1 ± 4.6
   77.4 ± 13.6
 58.1 ± 5.7
 90.2 ± 6.0
 64.1 ± 3.5
   56.5 ± 10.3
 55.9 ± 7.1
162.4 ± 5.6
 59.0 ± 8.4
 44.7 ± 5.7
   87.1 ± 10.1
 72.4 ± 3.9
 54.7 ± 9.8
  58.3 ± 10.2
160.9 ± 4.6
  60.6 ± 10.4
46.6 ± 8.0
  86.8 ± 10.0
  77.1 ± 14.8
Values are expressed as means ± SDs. There were no differences in the patient characteristics and baseline values between Group MS and Group 
MN, and between Group FS and Group FN, respectively. Group MS: male smokers, Group MN: male nonsmokers, Group FS: female smokers, 
Group FN: female nonsmokers, MAP: mean arterial pressure, HR: heart rate.
Fig. 1. Changes of the MAP (mean arterial pressure) (A) and HR (heart rate) (B) in the males. The MAP and HR at P0 and 1, 2 and 3 minutes 
in Group MS were higher than those of Group MN, respectively (P < 0.05). In Group MS, the HR was increased at P0 and 1, 2 and 3 minutes 
compared with that at baseline. Group MS: male smokers, Group MN: male nonsmokers, B: baseline, BO: on unconsciousness, BI: just before 
intubation, P0: just after intubation, P1, 2, 3: 1, 2, 3 minutes after intubation. *P < 0.05 compared with baseline, 
†P < 0.05 compared with Group MN.511 www.ekja.org
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intubation and 1, 2 and 3 minutes after intubation. In Group 
FN, the MAP was increased just after endotracheal intubation 
compared to the baseline MAP (98.4 ± 17.3 mmHg vs 86.6 ± 
10.0 mmHg, respectively) (Fig. 2A, P < 0.05). The heart rate in 
Group FN just after endotracheal intubation was higher than 
the baseline heart rate (88.6 ± 22.8 bpm vs 77.1 ± 14.8 bpm, 
respectively). It was significantly increased at 1 and 2 minutes 
after intubation (Fig. 2B, P < 0.05). In Group FS, the heart rate 
just after intubation was increased higher than that of baseline 
(88.9 ± 10.8 bpm vs 72.4 ± 3.9 bpm, respectively), and it was 
significantly increased at 1, 2 and 3 minutes after intubation 
(Fig. 2B, P < 0.05). But there was no difference in the heart rate 
between Groups FN and FS (Fig. 2B).
Discussion
    Endotracheal intubation is a commonly used, necessary 
maneuver for securing the airway when inducing general 
anesthesia. However, endotracheal intubation causes the 
stimulation of the sympathetic nervous system, which increases 
the plasma catecholamine level and this can cause an elevated 
blood pressure and tachycardia [9]. Most myocardial ischemia 
that occurs during anesthesia is related to endotracheal 
intubation and especially to tachycardia [10]. So it is important 
to prevent hemodynamic changes during anesthetic induction.
    To minimize such cardiovascular responses, the use of opioids, 
local anesthetics, inhalational anesthetics, beta adrenergic 
blockers, calcium channel blockers and other cardiovascular 
drugs has been shown to be effective [11]. Among them, opioids 
have been the most widely used drugs. Fentanyl blocks the 
sympathetic nervous responses during anesthetic induction. 
The amount of fentanyl used for endotracheal intubation with 
using a laryngoscope is known to be directly proportional to 
the ability to suppress the cardiovascular response, so fentanyl 
has often been used [12], yet remifentanil has recently become 
more widely used.
    There have been many studies on what the appropriate 
dosage of remifentanil is in order to suppress the hemodynamic 
response to endotracheal intubation. The methods of 
administration are a bolus injection, an injection of a loading 
dose with a continuous infusion, and a continuous infusion. 
For the induction of anesthesia using propofol and rocuronium, 
Hall et al. [13] administered a loading dose of remifentanil 0.5 
μg/kg and then they continuously infused 0.25 μg/kg/min. Shim 
et al. [2] reported that continuously infusing remifentanil at 0.2 
μg/kg/min effectively suppressed the stimulus-caused increase 
in blood pressure and heart rate. Their results show that the 
amount of remifentanil administered until endotracheal 
intubation was important for inhibiting the hemodynamic 
response regardless of the method of administration. The 
optimal dose was normally 1-1.5 μg/kg. This current study 
followed the methodology of the study by Shim et al. [2] by 
inducing anesthesia for 6-7 minutes until endotracheal 
intubation. Thus, we were able to avoid side effects such as 
muscle rigidity induced by a bolus injection of remifentanil 
[14,15]. 
    There have been many studies done on the effects of smoking 
on the cardiovascular system. According to McVeigh et al. 
[16], the resting heart rate was higher in smokers than in 
nonsmokers. They also reported that the systolic and diastolic 
pressures and the MAP were lower in smokers than those 
in nonsmokers. In a study on only women, Laxton et al. [6] 
asserted that heart rate of smokers immediately after intubation 
was significantly greater than that of nonsmokers. Yet Jee and 
Fig. 2. Changes of the mean arterial pressure (MAP, A) and heart rate (HR, B) in women. The HRs during postintubation period were increased 
compared with baseline in each group (P < 0.05), but there were no differences between the two groups. Group FS: female smokers, Group 
FN: female nonsmokers, B: baseline, BO: on unconsciousness, BI: just before intubation, P0: just after intubation, P1, 2, 3: 1, 2, 3 minutes after 
intubation, respectively. *P < 0.05 compared with baseline.512 www.ekja.org
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Park [17] argued that the baseline blood pressure and heart 
rate are not different for smokers and nonsmokers. In fact, in a 
non-stimulated state, nicotine affects the sympathetic nervous 
system, it elevates the heart rate and it causes vasoconstriction. 
Smokers who abstained from smoking for a short period of 
time experience a reduction in the plasma catecholamine 
level, which reduces the heart rate and arterial blood pressure 
[18]. This current study showed no difference in the baseline 
heart rate or MAP between the smokers and nonsmokers. So 
our research findings were in accordance with the findings 
of Jee and Park [17]. But the difference in research findings 
among the different studies is construed to be due to the 
different characteristics of the patient subjects such as their age, 
their history of smoking and their history of abstinence from 
smoking. 
    Smoking elevates the blood pressure and the heart rate, but 
abstinence from smoking during a period of preparation for 
surgery shows various hemodynamic responses depending on 
the duration of abstinence and the patients age and gender. 
Further research needs to be done on this. Moreover, there is no 
study on the effect of the smoking period on the cardiovascular 
system, so this needs further research as well. 
    Smoking has a strong adrenergic agonistic effect, and so it 
increases the blood pressure, heart rate and systemic vascular 
resistance [19]. The change in heart rate is controlled by the 
autonomic nervous system. The effect the autonomic nervous 
system has on the sinus node is ever-changing due to internal 
and external factors. The regular change in the heart rate is 
called heart rate variability. Smoking is said to reduce such 
heart rate variability [20]. Such reductions are a serious risk 
factor for cardiac diseases [21,22]. Smokers are two times more 
as likely to suffer from coronary arterial diseases than are 
nonsmokers [23,24].
    This study showed that there was a difference in the 
hemodynamic response to endotracheal intubation between 
male smokers and nonsmokers, while there was not such a 
difference in the female groups. Jee and Moon [25] reported 
that men have a longer sustained elevation of systolic blood 
pressure. It appears that the length of the blood pressure 
elevation is gender-based, so it is believed that gender also 
affects the change in hemodynamic responses. Hinojosa-
Laborde et al. [26] reported that there is a gender difference 
in the control of the sympathetic nervous system. The control 
of the sympathetic nervous system in women is a bit more 
efficient than that in men. In this study, there was no difference 
in the endotracheal intubation-caused hemodynamic response 
in the women groups, regardless of whether they smoked or not. 
Perhaps this is because the efficient control of the sympathetic 
nervous system offsets the hemodynamic responses.
    In conclusion, for men, there was a difference in the hemo-
dynamic response to endotracheal intubation using remifen-
tanil between the smokers and nonsmokers. However, for 
women, there was no such difference. There has been much 
controversy over the gender difference of the endotracheal 
intubation-caused hemodynamic change. For obtaining 
consistent results, more research should be performed with 
controlling for many factors.
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